13D Filings
Novabay Pharmaceuticals, Inc.
NBY
Amendment
Ownership

17.52%

Total Shares

1,020,300

Issuer CIK

1389545

CUSIP

66987P409

Event Date

Sep 2, 2025

Accepted

Sep 4, 2025, 07:21 PM

Reporting Persons (4)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Poplar Point Capital Management LLC
Investment Adviser
17.52%1,020,30001,020,300
Poplar Point Capital Partners LP
Partnership
17.52%1,020,30001,020,300
Poplar Point Capital GP LLC
Holding Company
17.52%1,020,30001,020,300
Jad Fakhry
Individual
17.52%1,020,30001,020,300
Disclosure Items (7)

Security Title

Common Stock, par value $0.01 per share

Issuer Name

Novabay Pharmaceuticals, Inc.

Issuer Address

2000 Powell Street, Emeryville, CA, 94608

Filing Persons

(i) Poplar Point Capital Management LLC ("PPCM"), is a Delaware limited liability company; (ii) Poplar Point Capital Partners LP ("PPCP"), is a Delaware limited partnership; (iii) Poplar Point Capital GP LLC ("PPCGP"), is a Delaware limited liability company; (iv) Jad Fakhry ("Mr. Fakhry"), a United States citizen (collectively with PPCM, PPCP and PPCGP, the "Reporting Persons"). PPCM is the investment manager for PPCP. PPCGP is the general partner of PPCP. Mr. Fakhry is the manager of, and owns a controlling interest in, PPCM and PPCGP.

Business Address

The address of the principal business and principal office of each of the Reporting Persons is: 330 Primrose Road, Suite 400 Burlingame, CA 94010

Principal Occupation

The principal business of the Reporting Persons is investing securities. The principal occupation of Mr. Fakhry is serving as the Manager of Poplar Point.

Convictions

During the past five years, none of the Reporting Persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Citizenship

PPCM is a Delaware limited liability company. PPCP is a Delaware limited partnership. PPCGP is a Delaware limited liability company. Mr. Fakhry is a citizen of the United States of America.

PPCM directly holds 1,020,300 shares of Common Stock. Consideration for these assets came from working capital of PPCM.

The purpose of the acquisition of the Common Stock is for investment, and the acquisitions of the Common Stock were made in the ordinary course of business. Given the Reporting Persons' ownership percentage of the Issuer, the Reporting Persons holding of the Common Stock may have the purpose or effect of control. At this time, the Reporting Persons have no specific plan or proposal to acquire additional Common Stock or dispose of the Common Stock.

Percentage of Class

(i) PPCM 1,020,300 17.52% (ii) PPCP 1,020,300 17.52% (iii) PPCGP 1,020,300 17.52% (iv) Jad Fakhry 1,020,300 17.52%

Number of Shares

(i) PPCM Sole Voting Power - 0 Shared Voting Power - 1,020,300 Sole Dispositive Power - 0 Shared Dispositive Power - 1,020,300 (ii) PPCP Sole Voting Power - 0 Shared Voting Power - 1,020,300 Sole Dispositive Power - 0 Shared Dispositive Power - 1,020,300 (iii) PPCGP Sole Voting Power - 0 Shared Voting Power - 1,020,300 Sole Dispositive Power - 0 Shared Dispositive Power - 1,020,300 (iv) Jad Fakhry Sole Voting Power - 0 Shared Voting Power - 1,020,300 Sole Dispositive Power - 0 Shared Dispositive Power - 1,020,300

Transactions

In the past 60 days, the following transactions were effected by the Reporting Persons, in normal course of business: Not applicable.

Shareholders

No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.

Date of 5% Ownership

Not applicable.

Other than as described in this Statement, to the knowledge of the Reporting Persons, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the Reporting Persons or between the Reporting Persons and any other persons with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of proxies.

JOINT FILING AGREEMENT The undersigned hereby agree to jointly prepare and file with regulatory authorities this Schedule 13D and any future amendments thereto reporting each of the undersigned's ownership of securities of the Issuer named herein, and hereby affirm that such Schedule 13D is being filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated this 4th day of September, 2025 POPLAR POINT CAPITAL MANAGEMENT LLC By: /s/ Jad Fakhry Jad Fakhry, Manager POPLAR POINT CAPITAL PARTNERS LP By: Poplar Point Capital GP LLC its General Partner By: /s/ Jad Fakhry Jad Fakhry, Manager POPLAR POINT CAPITAL GP LLC By: /s/ Jad Fakhry Jad Fakhry, Manager /s/ Jad Fakhry JAD FAKHRY, an individual

Novabay Pharmaceuticals, Inc. — Schedule 13D | 13D Filings